Nucleic Acids Research, 2002, Vol. 30, No. 17 3748-3753
© 2002 Oxford University Press
Sequence-specific protection of plasmid DNA from restriction endonuclease hydrolysis by pyrroleimidazolecyclopropapyrroloindole conjugates
Division of Biofunctional Molecules, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Surugadai, Kanda, Chiyoda, Tokyo 101-0062, Japan
*To whom correspondence should be addressed. Tel: +81 03 5280 8032; Fax: +81 03 5280 8127; Email: sugiyama.chem@tmd.ac.jp
The pyrroleimidazole (PyIm) triamidecyclopropa pyrroloindole (CPI) conjugates ImPyImLDu86 (7) and ImImPyLDu86 (14) were synthesized and their alkylating activities and inhibitory effects on DNA hydrolysis by restriction endonucleases were examined. Sequencing gel analysis demonstrated that conjugates 7 and 14 specifically alkylated DNA at 5'-CGCGCG-3' and 5'-PyGGCCPu-3', respectively. Agarose gel electrophoresis indicated that incubation of a supercoiled plasmid, pSPORT I (4109 bp), with conjugate 7 effectively inhibited its hydrolysis by BssHII (5'-G_CGCGC-3'), whereas conjugate 14 had no effect on this hydrolysis. These results suggest that conjugate 7 sequence-specifically inhibits the hydrolysis of DNA by BssHII. Sequence-specific alkylation by the PyIm triamideCPI conjugates was further confirmed by inhibition of the Eco52I (5'-C_GGCCG-3') hydrolysis of conjugate 14-treated pQBI PGK (5387 bp). In clear contrast, hydrolysis of pQB1 PGK by DraI (3'-TTT_AAA-3') was not inhibited by 5 µM conjugate 14. That ImImPy did not inhibit the hydrolysis of pQB1 PGK indicates that covalent bond formation is necessary for inhibition. A similar experiment, using linear pQBI PGK, achieved the same extent of protection of the DNA with approximately half the concentration of conjugate 14 as was required to protect supercoiled DNA from hydrolysis.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E.-H. Yao, N. Fukuda, T. Ueno, H. Matsuda, H. Nagase, Y. Matsumoto, H. Sugiyama, and K. Matsumoto A pyrrole-imidazole polyamide targeting transforming growth factor-{beta}1 inhibits restenosis and preserves endothelialization in the injured artery Cardiovasc Res, March 1, 2009; 81(4): 797 - 804. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-H. Yao, N. Fukuda, T. Ueno, H. Matsuda, K. Matsumoto, H. Nagase, Y. Matsumoto, A. Takasaka, K. Serie, H. Sugiyama, et al. Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Attenuates Restenosis of the Artery After Injury Hypertension, July 1, 2008; 52(1): 86 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Matsuda, N. Fukuda, T. Ueno, Y. Tahira, H. Ayame, W. Zhang, T. Bando, H. Sugiyama, S. Saito, K. Matsumoto, et al. Development of Gene Silencing Pyrrole-Imidazole Polyamide Targeting the TGF-beta1 Promoter for Treatment of Progressive Renal Diseases J. Am. Soc. Nephrol., February 1, 2006; 17(2): 422 - 432. [Abstract] [Full Text] [PDF] |
||||


